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ABSTRACT 
Delays in seeking effective treatment for tuberculosis increase the level of disease 
morbidity and mortality rate as well as the risk of its transmission in the community (WHO, 
2006b). In Somalia, Tuberculosis (TB) remains one of the greatest health threats as it is the 
leading cause of death in the economically active age groups and in people living with 
HIV/AIDS (WHO, 2004). This study was carried out with the aim of determining factors 
influencing delays in seeking TB treatment in Belet-Weyne district.  
A cross-sectional study of 132 newly diagnosed smear-positive tuberculosis patients 
who were within the first two months of their intensive phase of treatment ,was conducted in 
the Zamzam Directly Observed Treatment (DOT) Centre in Belet-Weyne town, from June 1, 
2007 to August 15, 2007. Data was collected using a pre-tested interview guideline with 
semi-structured questions. Data entry and analysis was done using SPSS 11.5 for Windows 
and EPI Info 6. Results were compared using chi- square (χ2) test, Fisher’s Exact test, linear 
regression analysis and multivariate logistic regression analysis.  
The study found that 53.8% of the new smear positive pulmonary TB cases in 
Zamzam TB centre of Belet-Weyne delayed in seeking TB treatment by 60 or more days. 
The median time interval between the onset of symptoms and treatment initiation was 68.0 
days. The study found that the TB patients had average levels of knowledge and perceptions 
about TB. However, it was also noted that overall knowledge regarding transmission, 
prevention and recovery among respondents was quite low. Despite the respondents’ average 
knowledge on TB, the study found patients had some misconceptions about the causes of TB, 
which included the belief that symptoms were the result of a   bad cold, smoking, or being 
overworked; others falsely believed the condition was hereditary, or caused by witchcraft, or 
the evil eye, or caused from trauma or shaking hands and other forms of physical contact.  
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This study found that age, distance to treatment centre, level of perception and stigma 
were associated with delay in seeking TB treatment.  However, level of perception and 
stigmatization were the only factors found to be significantly associated with delay in TB 
treatment after controlling for confounding factors. Patients that were highly stigmatized 
were 2.6 times more likely to delay in seeking treatment than those with low stigmatization 
(p= 0.03; OR = 2.624, CI: 1.101–6.254).  Patients with a high perception regarding TB were 
found to be 0.368 times less likely to delay in seeking treatment than those with a low 
perception (p= 0.047; OR = 0.368, CI: 0.137– 0.988).  Age of patient, stigma scores and 
distance to the treatment centre were significantly associated with treatment delay when 
linear regression analyses were conducted. However, they were not significant after 
controlling for other factors, when logistic regression analysis was performed.  
The findings of this study suggest that establishing TB education programs for the 
public and focusing on reducing stigma will encourage population to seek appropriate 
medical consultation, improving case detection and subsequently reducing delay of 
treatment. 
Private health practitioners (e.g. traditional healers, pharmacists, etc.) should be 
trained in handling TB cases, especially in early diagnoses. There is also need for public 
health facilities to increase accessibility to TB treatment, especially targeting patients with 
high potential for delay in seeking treatment for the effective control of TB in Belet-Weyne 
district.  
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1. INTRODUCTION 
1.1 Background  
Tuberculosis (TB) is an infectious disease that spreads through the air from person to 
person. It is caused by Mycobacterium TB. When a person with TB of the lung coughs, 
sneezes, talks or even sings, the bacteria are sprayed out into the air as infectious droplets. 
These droplets dry up rapidly but the smallest of the droplets remain suspended in the air for 
several hours.  Not all infected individuals develop TB - approximately 10% develop the 
disease (Kim, 2002). TB is a major public health concern globally; and is rated second only 
to HIV/AIDS as a cause of morbidity and adult mortality, accounting for nearly nine million 
cases of active disease and two million deaths in 2004 (WHO, 2005). 
In 1993, the World Health Organization (WHO) declared a state of global emergency 
for TB due to the steady increase of the disease worldwide. In 1995 Directly Observed 
Treatment Short-course (DOTS) strategy was established as the key intervention to achieve 
TB control worldwide. The global targets of this strategy were to achieve 70% case detection 
and 85% cure rates by 2005 (WHO, 2002). In 2003, DOTS programmes successfully treated 
84% of all registered new smear positive patients, but detected only 28% of the estimated 
tuberculosis cases in the world (WHO, 2002). Early diagnosis and prompt effective therapy 
form the key elements of the tuberculosis control programme. Delay in diagnosis results in 
increased infectivity in the community and it is estimated that an untreated smear-positive 
patient can infect, on average, 10 contacts annually and over 20 during the natural history of 
the disease until death. (WHO, 2006b). Delay in tuberculosis diagnosis may also lead to a 
more advanced disease state at presentation, which contributes to late sequelae and overall 
mortality. Smear-positive cases are more likely to infect other individuals (Styblo, 1991). 
 
 
 
 
 2
Case detection was estimated at 53% globally in 2004 (WHO, 2005). The number of 
TB cases has, however, been growing in Africa where the TB epidemic is still driven by the 
spread of HIV.  More than 80% of all TB patients live in sub-Saharan Africa and Asia 
(WHO, 2005). In Somalia, TB remains one of the greatest health threats and is a leading 
cause of death in the economically active age groups, especially due to the risk of dual 
HIV/AIDS and TB infection (WHO, 2004).   By 2001, Somalia had a high tuberculosis 
burden with an estimated incidence rate of all forms of tuberculosis of 352/100 000, a smear 
positive case detection rate of 32% and a close to the target treatment success rate of 83%. 
With 100% DOTS coverage reached at the end of 2001, the smear positive case detection 
slightly increased to 37% by 2003 (WHO, 2003, WHO, 2006b). 
1.2 Problem Statement   
Somalia is among the countries with the highest TB incidences in the world (about 
372 per 100,000 populations), with approximately 25,000 expected TB cases per year.  The 
number of estimated smear positive cases is 11,000 per year (162 per 100,000 people) with 
80% of the cases occurring in the productive age group of 15-44 years. Tuberculosis is thus a 
major public health problem in Somalia. As in many other resource-constrained settings, 
treatment outcomes for TB have not been satisfactory in southern and central Somalia, 
mainly due to poor treatment compliance, low case detection and low coverage of DOT 
centers.  Barriers such as poverty, lack of knowledge /information, Stigmatization, lack of 
family support and complexity of the health care system in Somalia could delay seeking care 
or contacting a health care provider (SACAB, 2003). 
In Belet-Weyne District, a community based organization called Zamzam Foundation 
started a TB program in 2003. Zamzam TB centre is the first specialized TB treatment 
facility to begin operations in the region after the outbreak of civil war in Somalia in 1990. 
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The TB centre utilizes the most effective TB treatment strategy, the Directly Observed 
Treatment Short-course (DOTS) method. Since 2003, WHO has been providing the TB 
centre with TB medicines free-of-charge. In 2005, the cure rate among the TB patient in 
Belet-Weyne town was 65% and the defaulter rate decreased from 23.8 % in 2004 to 15.8 % 
in 2005.  
Reports from Zamzam indicate that the percentage of patients coming to the centre 
with positive smear sputum decreased from 21 % in 2004 to 15 % in 2005 and 12.3% in 
2006, while the multi-drug resistance among the defaulters increased from 1.2% to 2.9 % 
from December’05 to December’06.   Clinic data however indicated that nearly half of TB 
patients had symptoms for two months or more before seeking TB treatment (Zamzam, 2004-
2006). Delay in seeking care for TB may be detrimental not only to the individual, whose 
illness may be more severe, but also to the community, as ongoing transmission will continue 
until effective chemotherapy is instituted (Meursing, 1997)  
There is growing evidence that access to treatment remains difficult for a high 
number of tuberculosis patients in Somalia. The challenge posed by the low case detection 
rate in the Belet-Weyne district can be addressed by studying the delay in case finding. 
Understanding the causes behind the delay in seeking TB treatment is essential for all 
partners involved in tuberculosis control in Somalia and particularly in Belet-Weyne district, 
in order to improve the quality and effectiveness of the tuberculosis control programme. 
1.3 Purpose 
The purpose of this study is to understand the reasons for the delay in seeking TB treatment, 
in order to effectively modify the Zamzam TB program to reduce the delay.  The study will  
provide evidence for improving policies and programmes that will help enhance early case 
detection and treatment. 
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2.0 LITERATURE REVIEW 
2.1 Global Epidemiology of TB 
TB is one of the major causes of death from a curable infectious disease (WHO, 2004). 
Findings from results of surveys, surveillance systems and death registrations estimated that 
8·9 million new cases of TB were reported in 2004, less than half of which were reported to 
public-health authorities and WHO. About 3·9 million cases were sputum-smear positive, the 
most infectious form of the disease. The report further maintains that countries in Africa have 
the highest estimated incidence rate (356 per 100000 persons per year), but the majority of 
patients with TB live in the most populous countries of Asia. Bangladesh, China, India, 
Indonesia, and Pakistan together account for nearly half (48%) of the new cases that arise 
every year (WHO, 2004). According to Dye (2006), TB is first and foremost a disease of 
men. Where the transmission of Mycobacterium TB has been rising for many years, the 
disease is common in young adults with most TB cases are new infections in this case of 
rising incidence. Reservoirs for high levels of TB transmission rest predominantly in those 
with undiagnosed pulmonary disease. The contagion parameter suggests that where TB is 
endemic, each infectious case will result in between 20 and 28 secondary infections (Jochem, 
1999). The review by Harries et al, (2001) stated that in many African countries, the time 
between onset of symptoms and diagnosis of smear-positive pulmonary TB is about 3–4 
months, thereby increasing the spread of disease.  If detection occurred far closer to the onset 
of symptoms, secondary cases would automatically fall. 
2.2 TB situation in Somalia 
The actual scope of the tuberculosis problem in Somalia was first examined in the early 
fifties, when a tuberculin survey led to an estimation of the annual risk of infection (ARI) at a 
level of 8% in 1956. Another study conducted in 1986 estimated the ARI to be 3.7% (WHO, 
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2006 a).  In March 2006, WHO carried out a new tuberculin surveys throughout Somalia 
funded by Global fund for HIV/AIDS, TB and Malaria (GFATM).The surveys revealed that 
the ARI was at 2.26%. Assuming the Stýblo ratio of 50 new smear positives for each 1% 
ARI, the incidence of new sputum smear positive was 111/100,000, which assuming a total 
population of 8.495 million, yields 9430 new cases of smear positive TB and about 11316 
smear negative and extra pulmonary (WHO, 2006 a). 
In Somalia, TB mostly affects people of reproductive age, with about 56% of notified cases 
from the age group 15-34 years. It is also noted that men are more affected than women. In 
Somalia, TB is strongly correlated with poor economic conditions where many patients are 
refugees or returnees from neighboring countries and many others have lived for more than a 
decade in war zones. Malnutrition is also common among TB patients and HIV co-infection 
is rapidly increasing. (SACB, 2003).  
The TB Program achieved the regional target of DOTS in all parts of Somalia in 2000, by 
establishing at least one TB centre in each of the 18 regions. However, the vast regions with 
the nomadic lifestyle of Somalis contribute to the inaccessibility of these centers. The WHO 
increased the case detection rate through the expansion of the TB centers In 2006, 11,945 
cases were reported in health facilities in Somalia working under DOTS, of which 6,895 
were new smear positive cases with DOTS case detection rate of 71 % (WHO, 2006a) 
Case detection rates are lower in the North East Zone (34%) than in Central and South 
Somalia (29% and 63% respectively) where instability and limited number of TB hospitals 
have affected the provision of services to the population. The treatment success rate was 80% 
in 2000, with no significant regional differences (SACB, 2003). 
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2.3 Patient’s Delay of TB Treatment  
The starting point from which the delays in seeking treatment are measured is uncertain and 
there is no agreed definition as to what constitutes an acceptable delay. The cutoff point in 
studies of risk factors for an acceptable delay has been defined in two ways: either a panel of 
experts agrees on a reasonable period of time or, alternatively, the median delay in observed 
data is used. Panels of expert have agreed on an acceptable total delay of 30 days [Wandwalo 
ER, Morkve, 2000, pp-133-138) or 60 days (Pirkis, et al, 1996, pp. 389-390 and Martinho et. 
al. 2005)    
Knowledge and understanding of the delay behaviour is very important for every TB 
programme as an individual may live with one or more potentially serious symptoms for a 
month or more and not seek help. This is called delay behavior. Patient delay is defined as 
the time between when a person first suspects his own symptoms may be of TB and when he 
actually seeks treatment (Kawathana, 1998). A delayer is likely to be poorly educated and 
low class in the society (Yusuf, 2004). Older people delay longer than younger people and 
this situation is common to people with no regular contact with a health provider (Yusuf, 
2004). 
Study results from rural Ethiopia, indicate that patients' delay was found to average 30 days 
(Solomon et al, 2005). This is in accordance with other studies conducted in Ghana, by 
Lawn, S., Afful, B.& Acheampong J  (1998), which showed a median patients' delay of 3 – 4 
weeks. 
A multi-country study from seven countries of the WHO Eastern Mediterranean Region was 
conducted during 2003–2004 in order to study the extent of delay in the diagnosis and 
treatment of tuberculosis patients, and its determinants. The results showed that the mean 
duration of delay between onset of symptoms until treatment with anti-tuberculosis drugs, 
 
 
 
 
 7
ranged from one month and a half to 4 months in the different countries. The mean delay was 
46 days in Iraq, 57 in Egypt, 59.2 in Yemen, 79.5 in Somalia, 80.4 in Syrian Arab Republic, 
100 in Pakistan, and 127 in Islamic Republic of Iran. The main determinants of delay were: 
socio-demographic (illiteracy, suburban residence); economic; stigma; time to reach the 
health facility; seeking care from non-specialized individuals; and visiting more than one 
health care provider before diagnosis(WHO, 2006b). 
2.4 Knowledge and Perceptions of TB 
An individual’s knowledge, attitudes, and perceptions with respect to health in general and 
with a specific illness, such as TB influence his/her behavior.  
Good general knowledge of TB is important for both health care seeking and adherence to 
treatment. Studies from Malaysia (Lim et al., 1999).and Vietnam (Xu B et al. 2004) have 
shown that treatment is often delayed due to poor knowledge, particularly in lower 
socioeconomic groups. Many in these groups are not aware of the risks associated with long-
standing cough, they are not reached by national programmes, and they do not recognize the 
need for prompt case detection, follow-up and treatment. Weintraub (1975) reported that the 
significant reason for the increasing prevalence of TB is poor patient compliance with 
treatment regimens. Although some patients may have sufficient knowledge of their disease 
or treatment objectives, there is a poor correlation between having such knowledge and 
adherence to treatment and follow-up. Weintraub concluded that TB control programs that 
use incentives to improve adherence to a medication regimen or the direct observed therapy 
method, in which the taking of medication is directly observed have the potential to increase 
TB cure rates.  
 A study done in Mankweng in Limpopo province, South Africa among community 
members, revealed that majority of the respondents perceived the cause of TB as smoking. 
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The perceived cause of cigarette smoking may be associated with TB because many other 
lung diseases such as emphysema and lung cancer are caused by smoking. Symptoms are the 
same – cough, phlegm etc. Moreover, smoking reduces appetite among some, but not all and 
that can cause them to become thin. Similarly, people infected with TB may become thin. 
This study also mentioned other misconceptions, such as TB being transmitted through dust, 
dirty air, and chemicals, eating unclean food, using dirty dishes, drinking unclean water and 
drinking alcohol (Supa & Peltzer, 2005, pp.74-81). 
With reference to health care, in the Lusaka urban health centres study, delay was associated 
with older age, severe underlying illness, poor perception of health services, distance from 
the clinic and prior attendance at a private clinic. There was no relationship between patient 
delay and knowledge about tuberculosis or with education, socio-economic level or gender 
(NRITLD, 2002). Patient delay was also found not significantly associated with patients' 
socio-demographic characteristics such as age, gender and educational level in a study carried 
out in Nigeria (Olumuyiwa et al., 2004).  
In another study conducted in Kenya, TB was perceived to be contagious, sensitive, and 
difficult to diagnose and treat.  According to the study, community members believe that TB 
should be diagnosed and treated in a hospital or by a medical doctor and not at the peripheral 
level. Many participants also believed TB to be hereditary. Prolonged incidences of self-
treatment and consultation with the traditional health sector as well as the social stigma 
attached to the disease increase patients’ delay (Liefooghe, et al, 1997). According to a 
review  (Brown, 1999), individual perception of the disease threat is composed of a personal 
perception of susceptibility to and severity of a certain disease. Personal perception of 
severity of a disease refers to feeling concerned about the seriousness of contracting an 
illness as an evaluation of the medical consequences e.g. death, disability and possible social 
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consequences. When individuals feel that they are at risk of contracting a certain disease, 
they may or may not act to protect themselves from that situation. This means that the two 
factors combined, perceived susceptibility and perceived severity of certain diseases bring 
about the individual psychological readiness to take proposed action (Brown, 1999). 
In a study conducted in Ethiopia aimed to determine the length of delay between the onset of 
symptoms and patient first visit to health care (patient delay) and length of delay between 
health care visit and diagnosis of tuberculosis, the time before diagnosis in TB patients was 
long and appeared to be associated with patient inadequate knowledge of TB treatment and 
distance to the health centre (Madebo T, Lindtjørn B. 1999). 
2.5 Stigma and TB 
Evidenced both in research and in practice, stigma associated with TB appears to be 
universal. The consequences of stigma can be seen affecting care-seeking behaviors, as 
persons have been known to hesitate or choose not to disclose their TB status to family, 
friends, and co-workers out of fear of being socially ostracized (Auer et al. 2000).  TB and 
HIV are closely linked in people’s minds in Lusaka and probably throughout the Southern 
African region, where as many as two thirds of TB patients may also be infected with HIV.  
Even patients who have been declared cured from TB are still socially disadvantaged 
(Meursing, 1997). Other studies have highlighted the silence and discrimination that 
surround people suffering from HIV and TB, that may deter people from seeking care 
(Meursing, 1997) and (Liefooghe, 1997).  It is possible that those with more severe 
symptoms may have underlying HIV disease and be less inclined to visit the clinic, fearing 
stigmatization (Liefooghe, 1997). 
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2.6 Study Aims  
Identify factors influencing delay in seeking TB treatment among patients utilizing the TB 
treatment at Zamzam centre, Belet-Weyne District  
2.6.1 Study Objectives 
1. To assess delay in seeking TB treatment, from onset of symptoms to initiation of 
treatment, among patients utilizing the TB treatment centre in Zamzam. 
2. To examine the relationship between socio-demographic factors and delay in seeking 
TB treatment among TB patients. 
3. To compare level of knowledge on TB amongst TB patients, who have delayed 
seeking TB treatment with patients who have not delayed treatment. 
4. To compare patient’s perceptions related to TB about the susceptibility, severity, 
benefits, and barriers among the TB patients who have delayed seeking TB treatment 
with patients who have not delayed treatment 
5. To compare accessibility to TB treatment among TB patients who have delayed 
seeking TB treatment with patients who have not delayed treatment. 
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3. METHODOLOGY 
This chapter presents the methodology adopted to investigate the delays in seeking TB 
treatment. The chapter describes operational definitions; study area, study population, 
sampling methods techniques and tools administered for documenting information, reliability 
and validity, data management and analysis and concludes with ethical aspects of this study.  
3.1 Study design 
This was a cross-sectional study to investigate factors influencing delays in seeking TB 
treatment in Belet-Weyne district in Somalia. 
3.2 Operational definitions  
i) TB symptoms: The following symptoms experienced by the patients are considered as 
TB symptoms in this study: 
• Cough for three or more weeks 
• Recurring fever in the evening and night 
• Chest pain 
• Weight loss 
• Haemoptysis (coughing of blood stained sputum) 
Any one of these symptoms was taken into consideration for estimating the date of onset 
of symptoms for study subjects (new smear positive pulmonary TB cases) 
ii) Delay for Pulmonary TB treatment: This is the time between onset of symptoms and 
initiation of pulmonary TB treatment.  This study has defined a delay of two months in 
seeking treatment as excessive, as no scientifically agreed criteria could be found in the 
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literature upon which to base a definition of delay. This definition was chosen only after 
having seen the distribution of delay times in our clinic patients. 
iii) Knowledge of TB: It is the understanding about the disease by research subjects. It was 
assessed by asking a few fundamental questions about cause, important symptoms, mode 
of transmission, diagnosis, and treatment of TB.  
iv) Perception related to TB: This is the patient’s recognition and interpretation of his 
feelings or emotions based on past experiences. It is the perception made by the study 
subjects, and was assessed by asking study subjects to respond to some fundamental 
statements about perceived susceptibility, perceived severity and perceived benefits of 
TB. 
v) Perceived Severity: Refers to the degree of seriousness and limitation imposed on life 
style, which an individual perceives. 
vi) Perceived treatment benefits: Refers to the degree to which an individual perceives 
his/her medication to be effective in controlling and preventing adverse consequences. 
vii) Perceived barriers: Refers to the degree to which an individual perceives there are 
barriers associated with use of the TB drug s for long period and unpleasantness, quality 
of hospital services in terms of health care provider manner. 
viii) Type of the first contact health care provider/worker: It is the type of health care 
provider consulted by the study subjects (TB patients) in the course of health care seeking 
for treatment of TB.  
ix) Accessibility (distance): It is the distance from the original residence /home of the study 
subjects to the current DOTS centre. It will be measured by asking study subjects about 
the Distance in KM taken from home to the treatment centre for the first time when they 
started the TB treatment. 
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3.3 Study area 
The study has covered the Belet-Weyne town in the Belet-Weyne district. There are two 
DOTS centers managed by local NGOs, with support from WHO. The study covered one of 
the DOTs centre named Zamzam clinic. The clinic was purposively selected due to ease in 
access and familiarity by the researcher. 
Study population  
All the new smear positive pulmonary TB patients registered in the Zamzam TB Treatment 
centre in Belet - Weyne district during their first two months of intensive phase of treatment 
were considered as the study population. This was matched with the exclusion criteria (see 
exclusion criteria below 3.9). 
3.4 Sampling and Sample size 
A cross-sectional survey was conducted among the study population, who were within the 
first two months of their intensive phase of treatment under DOTS. For this study, all 
subjects registered within the period of June 1, 2007 and August 15, 2007 in the Zamzam 
DOT centre in Belet-Weyne district were included.  There were 157 new cases of smear 
positive pulmonary TB found registered in the centre in the study period. Out of this, only 
132 cases were accessed for information in this study. Among the rest, 4 cases were 
transferred out, 5 defaulted, 2 died, 3 refused and 11 were excluded because they were below 
15 years of age. 
The sample size planned was calculated using a 2 tailed test. The sample size was determined 
by the use of a previous descriptive comparative cross-sectional study done in Thailand 
(Yusuf, 2004): which has shown that 50% of TB patients who delay in seeking treatment 
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have adequate knowledge on TB as compared to 34% of  TB patients who do not delay in 
seeking treatment have adequate knowledge. 
Primary outcome variable = in this study, the outcome of interest used for sample size 
determination was ‘overall level of knowledge on Tuberculosis’. 
The following formula for the sample size for comparison of 2 proportions (two-sided) was 
applied: -  
n = [A + B]2 * [(p1*(1-p1)) + (p2 * (1-p2))]/[p1-p2] 2  
where n = the sample size required in each group. 
p1 = first proportion with adequate knowledge for patients delayed (= 0.50)  
p2 = second proportion with adequate knowledge for patients not delayed ( = 0.34)  
p1-p2 = required size of difference  ( = 0.16)  
A = standard normal deviate for desired 95% significance level ( = 1.96) 
B = Is the table value for the desired 80% power ( =  0.84) 
Substituting the values in the above formula, the sample size per group is:  
n = [1.96 + 0.84]2 * [(0.50*0.50) + (0.34* 0.66)] / [0.16]2 = 146  
Therefore, the total the number of patients required in each group is 146. Given that the total 
number of TB patients in the study area was less than the determined sample size, all patients 
that satisfied the inclusion criteria were recruited in the study. 
.Inclusion criteria 
New smear positive Pulmonary TB patients above 15 years of age, during their first two 
months of intensive phase of treatment were included in the study. This was done to 
minimize recall bias of patients and access more patients.  
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Exclusion criteria 
The study excluded the research subjects based on the following conditions: 
• Patients below the age of 15 years at the date treatment started. This was confirmed by 
looking at the TB registers at the DOTS centre and patients' treatment cards before the 
interview. 
• Patients who defaulted before the date of data collection. 
• Smear negatives and relapsed or failed treatment were excluded from the study. This was 
based on the fact that if a patient is sputum negative, he/she may not have TB at all. 
• Patients with other complications together with TB e.g. heart disease, renal diseases or 
patients unwilling to participate in the study were excluded.  
3.5 Data collection Methods 
Before interviewing the patients, the numbers of eligible study subjects in the treatment 
centres were recorded by reviewing the TB registered at the clinic. With the permission of 
health workers at the DOTS clinic, patients coming to the centers for their treatment under 
DOTS were requested for consent and then interviewed for the required information. 
Information like date treatment started was recorded from the TB registers and TB treatment 
cards. To assure confidentiality, no permanent record of the study patients’ names and other 
information were made and patients were asked to participate in the study voluntarily. Data 
collected was used only for the purposes of the study and all information obtained during 
interviews was treated confidentially. Careful attention was paid to maintain the patient's 
comfort during the interview. It took approximately 35 to 45 minutes for a single interview.  
Pre-tested anonymous interview guidelines in the form of semi-structured questionnaire in 
Somali language were introduced to the study subjects by well-trained research assistants to 
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collect the information required. (Annex 3). There were two research assistants and the 
researcher participated in this study for information documentation. (Annex 1). Study 
subjects were asked TB treatment seeking history and their understanding about the disease, 
perception, stigma and some socio-economic issues such as family income, level of 
education, gender, resident status etc.  
3.6 Validity and Reliability  
A two days training of enumerators was conducted covering interview techniques, sampling 
procedure inclusion and exclusion criteria, identification of date of onset of symptoms of TB 
and the general courtesy during the study. 
The tools were pre-tested in one of the facilities offering DOTS services not selected for the 
main study prior to the start of study, with modifications incorporated in the final version.  
During piloting, the questionnaires were independently pre-tested using 5 volunteer patients 
by two different enumerators to assess their validity. After the pre-testing, views were 
exchanged to address the difficulties identified, appropriateness of the questions reviewed 
and appropriate changes made. Quality of data collection was given first priority throughout 
the study period. This included: close monitoring of patients, interviews by supervisors, 
cross-checking of completed questionnaires on daily basis, and daily reviews conducted with 
the survey teams to address any difficulties encountered. To ensure the external validity of 
the study was maintained, relevant literature was reviewed and opinions from the experts in 
the concerned field of TB research were obtained. 
3.7 Data management and analysis 
Data was entered into a database created using SPSS 11.5 for Windows. A preliminary 
analysis was done to facilitate coding of open-ended questions and recoding of variables 
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where necessary. Analysis was done using SPSS 11.5 for Windows. Data were analysed to 
compare the different risk factors among the TB patients who had delayed in seeking 
treatment with those who had not delayed in seeking TB treatment, as well as assess 
knowledge and perceptions related to TB. A 60 days cut-off on patients’ delay was used to 
estimate the time between onset of symptoms and initiation of treatment and to identify the 
risk factors associated with the delay in patients with TB. This 60 days cut off period was 
used to dichotomize the sample to either shorter or longer delay periods. 
The results are presented in form of tables and charts/diagrams. Descriptive statistics were 
determined during data analyses. The Chi-square (χ2) test, Fisher’s Exact test, and Logistic 
regression analysis were carried out. Logistic regression analysis was done in order to 
determine the effect of each of the considered variables on the outcome variable (i.e. delay in 
seeking TB treatment) independent of the others. 
In addition, linear regression analysis was performed to relate age, income and distance with 
TB treatment delay (taken as a continuous variable).  
The 5% significance level was used in all the statistical tests of significance conducted.  
3.8 Scoring and classification criteria  
Knowledge about TB was measured by scoring method. The correct answers were given a 
score of one (1) and an incorrect answer is given a score of zero (0) out of a total of 29. The 
level of knowledge was ranked into 'good knowledge', 'average knowledge' and 'poor 
knowledge' depending on the number of correct answers each patient gave out of the total 
questions. Thus, a composite variable was then produced and categorized as ≥ 80% (good 
knowledge), 50 – 79% (average knowledge) and < 50% (poor knowledge). Perception was 
rated as: 1 = Agree, 2= Uncertain, 3= Disagree. Thus, a composite variable was produced and 
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similarly categorized as ≥ 80% (good perception), 50 – 79% (average perception), and < 50% 
(wrong perception). Patients were also asked to respond on seven stigma-related statements 
contextual in the local socio-economic perspectives to assess their level of stigma, and 
categorized into 'highly stigmatized', 'average stigmatized' and 'less stigmatized' rankings. 
3.9 Ethical consideration  
An informed consent form was given and completed by each research subject before data 
collection. Prior to this, an information sheet comprising of the purpose of the study, 
potential risks and benefits of participating in the exercise, procedure of maintaining 
confidentiality, and right not to participate in the study were provided to the research subjects 
(Annex 5). The ethical approval was obtained from the Higher Degree Committee of 
University of Western Cape of South Africa, followed by Regional Health Authority (RHA), 
and management of Zamzam TB centre.  
3.10 Biases and limitations 
A selection bias could have been introduced in this study, as the study sample could not 
include those TB patients who were receiving their treatment entirely in the private sector.  
The private clinics were not using Direct Observed Treatment method with poor monitoring. 
The study focused on WHO supported centre where TB treatment services are free, hence the 
private sectors may not be represented. Therefore, the findings of this study need to be 
interpreted with caution. Another possible bias could have been recall bias among the 
subjects interviewed. However, every possible effort was made during the interview to 
minimize the recall bias, and also the patients included were in the intensive phase of their 
regular treatment under DOTS, mostly within the first one month. Also, another potential bias 
could be the definition of the cut-off values of delay chosen by the researcher, which is very 
much contextual. This bias however, should be minimal, since the cut-off values for defining 
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delay was taken after relevant literature were reviewed, and adequate discussion with the 
experts in field of TB care were made. Apart from using 60 days as a cut-off point,  similar 
analyses with different cut offs of 45 days, 75 days and 120 days were run in order to see if 
there could be any differences arising from recall bias. 
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4.0 FINDINGS 
4.1 Introduction  
This chapter presents the findings of the investigations of factors influencing delay in seeking 
TB treatment in Belet-Weyne district. The findings include socio-demographic factors of the 
study population, duration of treatment delay, knowledge and perceptions of TB patients and 
the level of stigma. Comparative analysis was done to describe the association of delay in 
seeking TB treatment with socio-demographic factors, knowledge and perception of disease, 
stigma and type of the first contact and the physical accessibility of the treatment centre.  
4.2 Socio –Demographic Characteristics  
Out of a total of 132 patients interviewed, 78 (51.9%) were males while the remaining 54 
(40.9) were females. A total of 62 (48%) of the respondents were married while 40 (30%) 
were single. The remaining 30 (28%) patients were widowed, separated or divorced. About 
three quarters (74%) of the respondents earned 50 USD or less per month. Overall, 43.9% of 
the respondents earned 30 USD or less per month, and 5% earned more than a 100 USD per 
month.  
The main source of income was subsistence farming for which 56% of the respondents were 
involved. Slightly over a half (57.6%) of the respondents were illiterate while only 4.5% had 
attained secondary level of education. The study also found that about two-fifths (41.7%) of 
the respondents were young patients in the age bracket of 15 – 34 years. The oldest 
respondent was 84 and youngest was 15 years.  
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Table 1: The socio-demographic characteristics of the study population. 
 
 Characteristic Number Percentage 
 
Gender 
Male 
Female 
Total 
 
78 
54 
132 
 
59.1 
40.9 
100.0 
Age (years) 
15-34 
35-54 
≥55 
Total 
 
55 
41 
36 
132 
 
41.7 
31.1 
27.2 
100.0 
Residential status 
Resident 
IDPs 
Internal migrant 
Returnees 
Total 
 
91 
6 
33 
2 
132 
 
68.9 
4.5 
25.0 
1.6 
100.0 
Marital status 
Married 
Single 
Widowed 
Separated 
Divorced 
Total 
 
62 
40 
21 
1 
8 
132 
 
47.0 
30.3 
15.9 
  0.8 
 6.1 
100.1 
Educational level 
Illiterate 
Literate/Primary (1-5) 
Lower secondary (6-8) 
Secondary (9-10) 
Total 
 
76 
20 
30 
6 
132 
 
57.6 
15.2 
22.7 
4.5 
100.0 
Occupation 
Skilled worker 
Unskilled worker 
Subsistence farmer 
Unemployed 
Total 
 
34 
17 
14 
7 
132 
 
25.8 
12.9 
56.1 
5.3 
100.1 
Monthly income(US dollar 
>$30 /Month 
<$30/month 
Total 
 
74 
58 
132 
 
56.1 
43.9 
100.0 
 
 
 
 
 22
 
4.3 Distribution of delay 
The study found that about half 53.8 % (CI: 44.9-62.5) of the new smear positive pulmonary 
TB cases in the Belet-Weyne town delayed by 60 or more days in seeking for TB treatment. 
The median time interval between onset of symptoms and initiation of treatment among the 
study population was 68.0 days with a mean 112.5, within a range of 7- 469 days having a 
standard deviation of 110. 96 days. Thirty-five percent of the subjects delayed in seeking TB 
treatment for a period of over 120 days (see chart 1).  
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Chart 1: Distribution of Delay in Seeking for TB Treatment 
4.4 Knowledge and TB 
Knowledge about TB was assessed by reviewing some fundamental statements about cause, 
important signs and symptoms, mode of transmission, diagnosis, prevention and recovery 
from TB infection. The level of knowledge was graded into 'good knowledge', 'average 
knowledge' and 'poor knowledge' depending on the number of questions the patients 
answered correctly from a set of 29 questions. 
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As shown in Table 2, most of the respondents were not aware of the causes of TB. Majority 
of patients (82.6 %) believed that TB is caused by bad cold, hard work and trauma (78.8%), 
smoking (67.9 %), heredity (68.9%) and witchcraft and evil eye (49.2%). Only 41.7% of the 
patients however had knowledge about the TB infection causing micro-organism.  
Over 90% of patients (95.5%) also thought that coughing for three weeks or more was a 
symptom of TB. An almost similar proportion of patients (93.2%) believed that fever in the 
evening and night was a symptom of TB, while chest pain (90.2%) and blood while coughing 
(86.4 %) were also cited as major symptoms TB. A relatively small percentage (41.7%) 
thought that headache is a sign of TB. 
However, most of the patients (71.2%), understood that TB is transmitted mainly through air 
droplets resulting from coughing by a TB patient and sharing common utensils/food (64.4%) 
while 71.2% believed that TB is transmitted through shaking hands.  Majority (97.7%) of the 
patients had said that TB can be diagnosed by sputum examination followed by chest x-ray 
(82.6%) and recognizing signs (62.9%), while the remainder  had no knowledge about the 
causes. 
Most of the patients did not know about the correct prevention of TB. Only (44.7 %) knew 
that covering the nose/mouth when coughing and sneezing is important for prevention, while 
37.1% mentioned vaccination as a method of TB prevention.  
Three-quarters of the subjects believed that TB can be cured through medication, 61.4% 
through traditional healing, while 39.4% of patients still believe that TB cannot be cured. 
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Table 2: Knowledge on TB 
Item Knowledge % 
 Yes* No  
Causes of TB   
Smoking and alcohol 
Germs/micro-organisms 
Hard work or trauma 
Witchcraft/evil eye 
Cold 
Hereditary disease 
30.3  
41.7 
21.2 
50.8 
17.4 
31.1 
69.7 
58.3 
78.8 
49.2 
82.6 
68.9 
Sign and symptoms   
Coughing more than three weeks 
Fever in the evening and night 
Chest pain 
Cough with blood 
Headache 
95.5 
93.2 
90.2 
86.4 
41.7 
4.5 
6.8 
9.8 
13.6 
58.3 
Transmission   
Coughing by TB patient 
Sharing utensils/food 
Hand shakes 
71.2 
67.4 
28.8 
28.8 
32.6 
71.2 
Diagnosis   
Blood examination 
Recognizing signs and symptoms 
Positive sputum 
Chest X-ray 
General body examination 
Stool and Urine examination 
32.6 
62.9 
97.7 
82.6 
54.5 
47.0 
67.4 
37.1 
2.3 
17.4 
45.5 
53.0 
Prevention   
Vaccination 
Covering nose/mouth when coughing and sneezing 
Avoid staying in crowded place 
Avoid being air conditioning room with smoke 
37.1 
44.7 
59.1 
43.2 
62.9 
55.3 
40.9 
56.8 
Recovery   
Curable through medication 
Self recovery 
Praying to God 
Traditional healing 
Cannot be cured 
75.8 
57.6 
91.7 
38.6 
60.6 
24.2 
42.4 
8.3 
61.4 
39.4 
*Correct answer = Yes   
On overall assessment of level of knowledge regarding TB, the study found that majority of 
respondents (72.2 %) had an average level of knowledge on TB, while (23.3%) of them had 
above average/good level of knowledge and only 4.5 % had poor knowledge. Slightly more 
than half (55.3 %) of the respondents had poor knowledge on causes of TB, while 15.2% of 
them had good knowledge. Knowledge of signs and symptoms was at a good level (83.3%) 
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across all the respondents. Knowledge of diagnosis was average at 68.9% while knowledge 
of transmission, prevention and recovery were averagely scored. 
 
Chart 2: Knowledge of TB summary 
4.5 Perceptions 
Level of perception (attitudes and beliefs about TB) was assessed by asking patients to 
respond to fundamental statements about perceived susceptibility, perceived severity, 
perceived treatment benefit and perceived barriers of TB health care. It was ranked into 'good 
perception', 'average perception', and 'wrong/poor perception'. Majority of the respondents 
(62.9%) perceived close contact with TB patients as a mode of TB transmission. More than 
half (58.3%) perceived that sharing food with TB patients might facilitate getting TB 
transmission, while 49.2% of the respondents perceived that living in crowded environment 
can easily transmit TB. 46.2% believed that living with a TB patient makes people vulnerable 
to TB infection. On perceived severity, three quarters (75.8%) of respondents agreed that TB 
is serious illness, while the rest were uncertain. Regarding the perceived benefits of TB 
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treatment, over 50% of the respondents perceived TB medication as effective in controlling 
and preventing adverse consequences. More than half (56.8%) of the respondents agreed that 
TB patients hardly got involved in social activities. About 63% of the respondents said that 
TB affects performance of their daily activities. On perceived barriers to accessing TB 
treatment nearly half (45.5%) of the respondents agreed that there were barriers affecting 
access to TB treatment as illustrated in table 3.  
Table 3: Perception of 132 TB patients by items 
 Level of perception (%) 
Item  Agree Uncertain Disagree 
Perceived susceptibility    
Close contact with TB patients 62.9 21.2 15.9 
Sharing food  with TB patient 58.3 17.4 24.2 
Living in crowded environment 49.2 22.7 28.0 
Sharing living quarters with TB patients 46.2 25.0 28.8 
Perceived severity    
TB is a serious illness 
Lack/Minimised social life 
TB can’t be cured 
Tb is not serious ,you can go on working anyhow 
TB affects working 
75.8 
56.8 
31.8 
22.7 
63.6 
13.6 
28.8 
22.0 
34.8 
25.0 
10.6 
14.4 
31.8 
42.4 
11.4 
Perceived benefits    
Anti-TB drug can stop the transmission 
Anti-TB drug can decrease death rate 
Poor or rich TB patients have equal chance to treatment 
TB patients who completed their treatment can live happily 
50.8 
47.7 
39.4 
52.3 
36.4 
27.3 
28.8 
31.1 
12.9 
25.0 
31.8 
16.7 
Perceived  Barriers     
It is difficult to take anti-TB drugs 
Access to TB drugs from hospital difficult 
Time is wasted undergoing treatment with anti-TB drug 
It is expensive to get TB treatment 
20.5 
45.5 
25.0 
22.0 
36.4 
34.1 
43.2 
39.4 
43.2 
20.5 
31.8 
38.6 
Table 4: Summary of Perception 
 Level of perception (%) 
Perception Good Average Poor 
Over all perception 44.7 54.5 0.8 
1. Perceived susceptibility  52.3 39.4 8.3 
2. Perceived severity 64.4 28.0 7.6 
3. Perceived benefit 40.2 53.8 6.1 
4. Perceived .barriers 28.8 64.4 6.8 
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4.6 Stigma 
Patients were asked to respond on seven stigma-related statements contextual in the local 
socioeconomic perspective, to assess the level of stigma, and categorized into 'highly 
stigmatized', 'averagely stigmatized' and 'less stigmatized'. As shown in table 5, the study 
found that slightly over one-third (37.1 %) of respondents would stay away from their 
neighbours and friends when they were infected  TB for the first time. Approximately  41% 
of them held the belief that people would be isolated when they got TB, whereas the rest of 
the respondents were not sure how the community would react on learning they had TB 
infection. Almost two-thirds (63.6%) of respondents said that they were not viewed the same 
way within their family or community after getting TB. About two-thirds (68.9 %) of the 
respondents held the belief that it would be difficult for an unmarried woman to find a suitor 
if she got TB, whereas 31% of them did not believe this was so. The statement "TB is the 
disease of the poor" yielded a 'yes' response from 41.7% and 'no' or “not sure” by 58.4%. 
Almost half (48.5%) of the respondents however believed that TB is the punishment for 
sinful acts committed in life (Table 5). 
Table 5: Stigma among TB patients 
Item Level of Stigma (%) 
 Yes Not sure No 
Preferred to be isolated on first contracting TB  37.1 28.0 34.8 
People would become lonely when they got TB  40.9 29.5 29.9 
TB patient are treated normally in family 25.8 10.6 63.6 
TB patient are treated normally in the neighborhood 36.4 21.2 42.4 
It is difficult for women to get married if they have TB.  68.9 18.9 12.1 
TB is the disease of the poor 41.7 32.6 25.8 
TB is a punishment for sinful act committed in life 48.5 22.7 28.8 
The study also established that 53.8% of the respondents were highly stigmatized as 
illustrated in the chart 3 below. 
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Chart 3: Level of Stigmatization 
 
4.6 Types of the first contact with a health care provider 
Patients were asked to do a history recall indicating their first point of contact with a health 
care provider, on onset of TB symptoms. Thirty-five percent of TB patients first consulted 
traditional healers on learning they had TB while the remaining visited drug 
shops/pharmacies (23.5%), private clinics (20.5%), TB clinics (18.6%) and village health 
workers (2.3%).  
4.7 Accessibility to the treatment centre  
Patients’ accessibility from their original homes to current treatment centre was assessed in 
terms of distance in kilometers (km). About two-fifths (43.2%) of the respondents traveled 
less than 5 kilometers while 31.8 % traveled  between 5 to 10 kilometers. The remaining 25% 
traveled more than 10 kilometers to reach the treatment centre as illustrated in chart 4 below. 
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Chart 4: Distance to treatment centre 
 
4.8 Relationships of factors to delay in seeking treatment 
The relationships between various factors and delay in seeking TB treatment among TB 
patients were assessed. This section is in two parts. The first part relates independent 
variables with categorized duration of TB treatment delay (i.e. delayed versus not delayed) 
while the second part presents results of linear regression analyses when age, income and 
distance were each regressed against duration of  treatment delay (taken as a continuous 
variable). 
4.8.1 Part 1: Relationships  
4.8.1.1 Socio –Demographic Characteristics versus delay 
The study established that the proportions of delay in TB treatment among male and female 
TB patients were equal (53.8% versus 53.7%, respectively), implying no significant 
difference (p=0.987). The other socio-demographic characteristics which were found not to 
have any significant influence on delay in seeking TB treatment included marital status, 
occupation and residential status. The study established that there was a statistically 
significant relationship between age, level of education and delay in seeking TB treatment. 
Older patients significantly delayed in seeking TB more than younger patients (p<0.05).  
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Those patients aged 35 – 54 years were 1.9 times more likely to delay in seeking TB 
treatment than those aged less than 35 years. Similarly, patients aged 55 years and above 
were about 3.9 times more likely to delay in seeking treatment than those aged less than 35 
years. TB patients with no formal school education were about two times more likely to 
delay in seeking treatment than those with formal school education (Odds ratio = 
2.16).Patients in lower income brackets were likely to delay by over two or more months. 
About two-fifths (43.9%) of the respondents earned 30 USD or less per month. They had a 
significantly higher delay rate when compared with the respondents who made more than 30 
USD (63.8% versus 45.9%). The difference was found to be statistically significant (p= 
0.0412). 
Table 6: Socio – Demographic Characteristics versus delay 
  Delay in seeking TB 
treatment 
Test statistic 
(Χ2 ) 
p-value 
  Delayed Not delayed 
Gender 
 
1. Male  
2. Female  
42(53.8) 
29(53.7) 
36(46.2) 
25(46.3) 
0.000 P=0.987 
Age (years) 1. 15-34 
2. 35-54 
3. ≥55 
22(40.0) 
23(56.1) 
26(72.2) 
33(60.0) 
18(43.9) 
10(27.8) 
9.21 P=0.01 
Residential 
status  
1. Resident 
2. Internal migrant 
3. IDPs/Returnees 
49(53.8) 
18(54.5) 
4(50.0) 
42(46.2) 
15(45.5) 
4(50.0) 
2.74 0.4341
Marital 
status 
1. Married 
2. Single 
3. Widowed 
4. Separated/Divorced 
35(56.5) 
19(47.5) 
11(52.4) 
6(66.7) 
27(43.5) 
21(52.5) 
10(47.6) 
3(33.3) 
3.44 p=0.94 
 
Educational 
level 
1. Illiterate 
2. Literate/Primary (1-5) 
47(61.8) 
24(42.9) 
29(38.2) 
32(57.1) 
4.675 0.025<p<0.05 
Occupation 1. Skilled worker 
2. Unskilled/unemployed 
3. Subsistence farmer 
16(47.1) 
12(57.1) 
40(54.1) 
18(52.9) 
9(42.9) 
34(45.9) 
3.50  0.3211 
Monthly 
income 
(USD) 
1. >30 /Month 
2. < 30/month 
34(45.9) 
37(63.8) 
40(54.1) 
21(36.2) 
4.17 0.0412] 
Note: Values in the parenthesis indicate percent computed row wise 
4.8.1.2 Knowledge and delay 
The results for the relationships between knowledge and delay in seeking T.B treatment 
among the study subjects are presented in Table 7.  The study established that there was no 
 
 
 
 
 31
statistically significant relationship between overall level of knowledge on TB and patient’s 
delay (P>0.05). Further analysis by each aspect of knowledge also found no statistically 
significant association with patient’s delay (P>0.05). However, the proportion of patients 
who delayed in seeking TB treatment among those with less knowledge about the causes of 
TB was higher than that among those with high knowledge on causes of TB (57.8% versus 
40.0%). Similarly, it was also found that 55.7% of the respondents with high knowledge on 
TB transmissions had delayed seeking TB treatment as compared to 50% among the patients 
with low knowledge on TB transmission. The respondents with low knowledge on TB 
prevention had delayed more than those with high knowledge of TB prevention. However, 
the proportion of delay in seeking TB treatment among patients with high knowledge of TB 
diagnosis was slightly higher than that among patients with low knowledge level about TB 
diagnosis, but none of the associations was found to be statistically significant  
Table 7: Association between knowledge and delay of TB patients (n=132) 
 Delay in seeking TB treatment  
Χ2 
 
P-value  Delayed (%) Not delayed (%)
 Overall knowledge  
             High  
             Low  
 
43(55.8) 
28(50.9) 
 
34(44.2) 
27(49.1) 
 
0.314 
 
0.575  
 Cause of TB 
             High  
             Low 
 
12(40.0) 
59(57.8) 
 
18(60.0) 
43(42.2) 
 
2.97 
 
0.084 
Sign and symptoms 
             High  
             Low  
 
68(55.3) 
  3(33.3) 
 
55(44.7) 
6(66.7) 
 
 
0.301 (using 
Fisher’s exact 
test) 
 Transmissions 
             High  
             Low  
 
49(55.7) 
22(50.0) 
 
39(44.3) 
22(50.0) 
 
0.38 
 
0.5370  
 Diagnosis 
             High  
             Low  
 
36(54.5) 
35(53.0) 
 
30(45.5) 
31(47.0) 
 
0.030 
 
0.861  
Prevention  
             High  
             Low 
 
22(47.8) 
49(57.0) 
 
24(52.2) 
37(43.0) 
 
1.010 
 
0.315 
Recovery  
            High  
             Low 
 
51(55.4) 
20(50.0) 
 
41(44.6) 
20(50.0) 
 
0.33 
 
0.564 
Note: Values in the parenthesis indicate percent computed row wise 
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4.8.1.3 Perception and Delay 
The proportion of the study population who delayed in seeking TB treatment among patients 
with overall low perception about TB was higher than that among patients with high 
perception (60.3% versus 45.8%). However, the difference was not statistically significant 
(p=0.096). 
 Delay in seeking TB treatment was found to be higher among those with high perception of 
TB severity as well as those with low perception of barriers to treatment accessibility (Table 
8). On perceived susceptibility, the proportion of patients who delayed in seeking TB 
treatment was the same for those patients with high and those with low perception (53.6% 
versus 53.9%). 
Table 8: Association between Perception and delay of TB patients (n=132) 
 Delay in seeking TB treatment χ2 test  P-value 
 Delayed (%) Not delayed (%)
Overall perception 
             High  
             Low  
 
27(45.8) 
44(60.3) 
 
32(54.2) 
29(39.7) 
 
2.764 
 
0.096  
Perceived Susceptibility 
              High 
              Low 
 
37(53.6) 
34(53.9) 
 
32(46.4) 
29(46.1) 
 
0.02 
 
0.8925 
Perceived Severity 
             High  
             Low  
 
49(57.6) 
22(46.8) 
 
36(42.4) 
25(53.2) 
 
1.43 
 
0.231 
Perceived Benefits  
             High  
             Low  
 
33(50.8) 
38(56.7) 
 
32(49.2) 
29(43.3) 
 
0.47 
 
0.4932 
Perceived Barriers 
             High  
             Low 
 
22(57.9) 
49(52.1) 
 
16(42.1) 
45(47.9) 
 
0.36 
 
0.547  
Note: Values in the parenthesis indicate percent calculated row wise 
4.8.1.4 Stigma and delay 
As shown in table 9, 59% of TB patients who were highly stigmatized, delayed in seeking 
TB treatment for more than 60 days since the onset of TB symptoms, while 35.2 % of lowly 
stigmatized patients delayed in seeking TB treatment. The difference was found to be 
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statistically significant (P=0.0062). Those who were highly stigmatized were 2.7 times more 
likely to delay in seeking TB treatment than those with low stigmatization. 
Table 9: Association between Stigma and delay of TB patients (n=132) 
 Delay in seeking TB 
Treatment 
   
Variable Delayed Not 
delayed 
χ2 test Odds ratio P-value 
Highly stigmatized (n=61) 
low stigmatized (n=71) 
36(59..0) 
 
 
25(35.2) 
 
25(41.0) 
 
 
46(64.8) 
7.48 
 
2.65 
(CI:1.23 - 5.76) 
0.0062 
Note: Values in the parenthesis indicate percent calculated row wise 
4.8.1.5 Types of the First Contact Health Care Provider and Delay of TB Patients 
Table 9 illustrates the relationship between types of the first contact health care provider and 
delay in seeking TB treatment. All the three patients that were first in contact with the village 
health worker delayed in seeking TB treatment. About 80% of patients that were first in 
contact with Traditional healer delayed in seeking treatment. The patients that had the least 
delay in seeking TB treatment was observed among patients who were in contact with the TB 
clinic (16.7%) followed by private clinic (29.6%). Overall, there was a statistically 
significant association between the type of the first contact health care provider and delay in 
TB treatment (χ2=34.68, P= 0.00005).  
Table 10: Types of the first contact health care provider and delay of TB patients 
 Delay in seeking TB 
Treatment 
  
Variable Delayed Not delayed χ2 test 2 P-value 
First  contact after onset of signs 
Drug shops/pharmacies 
Private clinic 
Village health worker 
Traditional healer 
TB clinic 
 
19(61.3) 
8(29.6) 
3(100.0) 
37(78.7) 
4 (16.7) 
 
12(38.7) 
19(70.4) 
0(0) 
10(21.3) 
20(83.3) 
 
 
34.68 
 
 
<0.00005 
Note: Values in the parenthesis indicate percent computed row wise 
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4.8.1.6 Distance to Treatment Centre versus Treatment Delay 
As shown in table 9, distance to the treatment centre was statistically significantly associated 
with patient delay (χ2=8.51, P=0.0142). The proportion of patients who delayed in seeking 
treatment was highest among patients who had to travel for a distance of 10 or more 
kilometers, followed by those who had to travel 0 - 5 Km., and least by those 5 – 10 km. 
away. From linear regression analysis, delay tended to increase with an increase with 
distance to treatment centre (p=0.024)  (Table 11) 
Table 11: Distance to Treatment Centre versus Treatment Delay. 
  Delay in seeking TB 
Treatment 
  
Variable Freq Delayed Not delayed χ2 test 2 P-value 
            Distance 
0-5 km 
5-10 km 
                    >10 -25km 
 
57 
33 
42
 
28(49.1) 
13(39.4) 
30(71.4) 
 
29(50.9) 
20(60.6) 
12(28.6) 
 
 
8.51; 
 
  
0.0142 
Note: Values in the parenthesis indicate percent computed row wise 
4.8.1.7 Results of Logistic Regression Analysis 
The results presented are from analysis conducted using a cut-off period of 60 days. 
Further analyses were also carried out using cut-offs of 45 days, 75 days and 120 days  
The following independent variables were selected for further analysis by logistic regression 
analysis because of either having been associated with delay in seeking TB treatment during 
the cross-tabulations or because of their importance in the relationships being sought: age, 
monthly income (in US$), type of first contact with the health care provider, overall level of 
knowledge on T.B, overall perception on T.B, distance to TB treatment centre, level of 
education and stigmatization.  
Level of perception and stigmatization were the only independent variables found to be 
statistically significantly associated with delay in TB treatment after controlling for other 
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variables in the model when 60 days was used as a cutoff point (Table 11). Those patients 
with low perception were 2.7 times more likely to delay in seeking TB treatment than those 
with high perception. Patients highly stigmatized were about 2.6 times more likely to delay in 
seeking treatment than those with low stigmatization. The remaining variables, namely, age, 
monthly income (in US$), type of first contact with the health care provider, overall level of 
knowledge on T.B, distance to TB treatment centre, and level of education were found not to 
be statistically significantly associated with TB treatment delay. However, when the cut off 
point was changed from 60 days to 45 days, 75 days or 120 days, it turned out that level of 
stigmatization was the only factor that had a significant effect on patient delay when other 
factors were controlled for. The results for these further analyses are presented in annexes 7-
11. The measure of strength of association (i.e. odds ratio) was lowest at 45 days’ cutoff 
point (OR = 2.5) and 60 days’ cutoff point (OR = 2.6) and highest at cutoff point of 75 days 
(3.268). The odds ratio for cutoff point of 120 days was 2.721.  
   Table 11:   Results of Logistic regression analysis. 
Variable B S.E. 
Wald’s statistic 
(χ2) df p-value Odds ratio 
95.0% C.I for odds 
ratio 
            Lower Upper 
 Age (groups) .475 .251 3.592 1 .058 1.608 .984 2.628 
  Monthly income .110 .364 .092 1 .762 1.117 .547 2.279 
  Level of education -.156 .233 .446 1 .504 .856 .542 1.352 
  Level of stigma .965 .443 4.736 1 .030 2.624 1.101 6.254 
  Type of first contact -.041 .130 .101 1 .751 .959 .743 1.239 
  Distance (KM) .333 .231 2.085 1 .149 1.396 .888 2.195 
   Overall knowledge   of TB .460 .554 .691 1 .406 1.585 .535 4.689 
  Overall perception of TB -1.000 .504 3.937 1 .047 .368 .137 .988 
  Constant -1.665 1.705 .953 1 .329 .189   
 
 
 
 
 
 
 
 36
4.8.2 Part II:  Results of Linear Regression Analysis 
Table 12 presents results when age, income, stigma scores and distance were regressed 
against duration of delay in seeking TB treatment. Age, distance and stigma scores were 
found to have a statistically significant effect on TB treatment delay despite low r-squared 
correlations, while the monthly income was found not to have any significant effect on 
treatment delay. Duration of delay tend to increase as age, distance and stigma  scores 
increase, while delay decreases with an increase in the monthly income. According to the 
findings, 5%, 3.9%, 1%, and 10.4 % of variation in treatment delay among TB patients was 
attributable to age, distance, monthly income and stigma scores, respectively.  This implies 
that factors other than the four considered in linear regression have a major role to play in 
delay in seeking TB treatment among the patients. The results were also confirmed by the 
Analysis of Variance (ANOVA) for the regression equations. 
Table 12: Results of Linear regression analyses 
 
Variables 
R 
square 
Adjusted 
R 
square  
 
Unstandarised 
coefficients Std,error 
Standaris
ed 
Coefficien
ts 
Coefficients 
Significance 95.0% C.I.for B 
   B  Beta  Lower Upper 
  
Age in years  
 
.051. 
 
.044 
 
1.356 
 
.552 
 
.227 
. 
.009 
 
0.354 
 
2.418 
   
Monthly income .010 
 
.002 
 
 
-.443 
 
 
.395 
 
 -.098 .264 
 
-1.224 
 
 
.338 
 
  Distance in  KM  .039 .031 1.463 . 642     .197 .024 1.93 2.734 
  Stigma scores .104 .097 2.166 .557 .323 .000 - - 
Predictors: (Constant), Age, Monthly Income, Stigma scores and Distance (KM) 
Dependent Variable:  # of days  delayed . 
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5. DISCUSSION 
 
This chapter discusses the findings in line with the objectives of the study as well the 
fundamental issues of delay in seeking TB treatment. 
5.1 Socio –Demographic Characteristics 
In this study, among the 132 smear positive pulmonary TB patients interviewed, slightly 
more men than women were interviewed (59.1% versus 40.9%). This finding is similar to a 
review by Dye (2006) which indicated that TB is more commonly found in men. 
Most of the respondents were aged 15 – 34 years indicating that majority of respondents 
were young adults. The number of patients who delayed in seeking TB treatment was 
significantly higher in the 35-55 year-age-group than in the 15-34 year-age group. Overall, 
age was found to have a statistically significant effect on patient delay. Delay significantly 
increased with an increase in age of the patient (p=0.009). This finding is in line with the 
findings of studies carried out in Lusaka and Lagos (NRITLD, 2002; Olumuyiwa et al., 
2004).  
About three-fifths of the respondents were illiterate. The high proportion of delay in seeking 
treatment was noted among less educated respondents (64.9 %). This appears to support the 
finding of a similar study carried out in West Africa, which established that delay in seeking 
treatment was longer in those who did not attend school or were illiterate (Lienhardt et al., 
2001). In this study, level of education was found to be significantly associated with delay in 
seeking TB treatment when considered on its own but on controlling for confounding, it was 
found not to have a statistically significant effect on treatment delay. This concurs with the 
findings of the study carried out in Lagos by Olumuyiwa et al. (2004). 
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Although there were some IDPs, returnees and internal migrants in the study, majority of the 
study patients (68.9 %) were residents of Belet-Weyne town. The findings from the study 
showed that patients who were subsistence farmers delayed in seeking treatment more than in 
other occupations. Possibly, the reason could be that the patients in this occupation had less 
time to seek treatment since they are busy with farming activities, although this was not 
conclusively confirmed by this study. 
Most of the respondents (73.5%) earned less than $30 per month. This was an indication that 
most of the study subjects came from low socio-economic status group. Poverty often 
precludes health seeking until the person can no longer be able to contribute to the livelihood 
of the family or household. This study confirmed that those earning less than $30 per month 
had the highest delay period as compared to those earning more than $30 per month. Monthly 
income was found to have a statistically significant effect on TB treatment delay when it was 
considered singly, in cross-tabulations although this was not the case when both linear 
regression and multiple regression (i.e. controlling for confounding) analyses were 
conducted.  
5.2 Delay in seeking TB treatment  
This study found that there was a substantial delay in seeking treatment for pulmonary TB 
from the time of onset of symptoms to initiation of treatment. This delay has great public 
health implications in densely populated as well as among the highly mobile population in 
Belet-Weyne town. Ideally, the duration of symptoms before treatment should be as short as 
possible to ensure a better outcome (WHO 2006b). However, considering the local situation 
and also referring to other studies that have used this cut-off point, this time frame is deemed 
appropriate for this study (Martinho et. al. 2005).  The researcher took a 60-day cut-off point 
for patient delay for measuring the length of patient’s delay. For this, some fundamental 
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symptoms namely coughing for three weeks or more, fever in the evening and night, chest 
pain, weight loss and presence of blood when coughing were among the major symptoms 
considered when suspecting TB infection. Majority of the patients had identified continuous 
coughing for three or more weeks and fever as important indicators for TB infection. 
In this study, the median of patient delay of 86 days (mean 112.5 days) was higher than those 
obtained in previously carried out studies in Ethiopia and Ghana which found median 
patients' delay of 30 days and 3 – 4 weeks, respectively (Solomon et al, 2005, Lawn S., Afful 
B. & Acheampong J, 1998). These differences could perhaps be attributed to better health 
care systems in these countries, with improved access to health care. However, a multi 
country study of seven countries including Somalia, conducted in 2006 reported higher rates 
of delay, which for Somalia was reported at 79.5days, which is consistent with the findings 
of this study. The main determining factors listed again were somewhat consistent with the 
findings of this study, of socio-demographic (illiteracy, suburban) stigma, time to reach the 
health facility and seeking care from non specialized individuals (WHO 2006b).  
5.3 Knowledge of TB 
Knowledge is an essential component in self-care. There is a growing perspective of need to 
acquire knowledge about the risk associated with TB infection in order to curb further 
infection and spread. Lack of awareness of the risk posed to the community by sputum 
positive pulmonary cases is a major impediment in the control of TB.  
Knowledge on signs and symptoms across the entire study population was particularly at 
good level (93.1%) as the respondents were familiar with the signs of TB. Despite the good 
knowledge, however, majority (55.3%) of them still delayed in seeking treatment, especially, 
when compared to those with low knowledge. 
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Despite the respondents’ overall good level of knowledge on TB, this study found some 
misconceptions about the cause of TB, especially regarding signs and symptoms as well as 
causes of TB. A similar study carried out in Mankweng, Limpopo province, South Africa 
(Supa, & Peltzer, 2005) reported that the proportion of patient’s delay among those who 
knew less about causes of TB was higher than the proportion among those who had high 
knowledge on causes of TB. This study found the overall knowledge on transmission, 
prevention and recovery among respondents to be quite low. This can however be linked to 
low levels of education since majority of them were illiterate and had little information on 
TB. The knowledge of TB diagnosis among the study population was at an average, as most 
of the respondents had correctly mentioned at least two main methods used in TB diagnoses, 
mainly sputum examination and chest x-ray. 
This study established no statistically significant difference between delay and knowledge of 
tuberculosis (P>0.05). This concurs with the findings of NRITLD (2002), and Olumuyiwa et 
al. (2004) but inconsistent with those obtained in a study conducted in Ethiopia by Madebo 
and Lindtjørn (1999), who found length of delay between the onset of symptoms and patient 
first visit to health care to be associated with patient inadequate knowledge of TB treatment. 
5.4 Perceptions of TB patients 
The overall perception of severity, curability, outcomes of majority (55.3%) of the study 
subjects was found to be low.  
This study found a considerable difference in patient delay among patients with high overall 
perception on tuberculosis and those with low perception (48.8% versus 60.2%). However, 
the difference was found not to be statistically significant when considered singly, but 
statistically significant when logistic regression analysis was conducted. 
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In relation to perceived severity, the proportion of patients’ delay among those with high 
perception was higher than those with poor perception (57.6% versus 46.8%), but the 
association between perception of severity and delay in seeking TB treatment was found not 
to be statistically significant (p=0.231). Respondents with low levels of perception on 
barriers were found to have delayed more or less the same as those with high perception of 
the same.  More than half of the respondents perceived that susceptibility was related to close 
contact with TB patients and sharing food with TB patients. One possible reason for this is 
that they perceived TB infection as a dangerous and contagious disease which is incurable. 
This perception has many social implications, such as, stigmatization and social isolation of 
TB patients and their families.  Studies from different cultures in Africa have consistently 
reported this popular perception. Although strict separating of eating and drinking utensils 
for TB patients contributes to general hygiene; it can also prevent TB transmission 
(NRITLD, 2002). Only 46.2% still perceived that living with TB patients will make them 
vulnerable to infection with TB disease. They incorrectly perceived that TB was only slightly 
dangerous or a harmless disease and did not consider themselves vulnerable to TB.  Only 
22.7 % of the respondents perceived that TB is not serious and will not affect their working 
habits and thus they could continue with their daily activities even if they got TB.  Slightly 
over half (56.8%) of the respondents agreed that TB patients hardly have social activities. 
The reason for this perception is that TB drugs cannot easily cure TB disease and severity of 
disease is long, so patients often feel barriers in participating in social activities. On 
perceived barriers to accessing TB treatment, nearly half (45.5%) of the respondents agreed 
that there were barriers affecting access to TB treatment, although they were not significantly 
associated with treatment delay. The above mentioned misperceptions among some of the 
study subjects regarding the performance of TB drugs, TB being either slightly dangerous or 
a harmless disease may contribute to delay in seeking treatment for it. For those that perceive 
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TB as a serious disease may be stigmatized as they may not want other people to know their 
disease status and hence delay in seeking treatment.  Some of perceptions  items  such  as 
that TB is not a serious disease , it has an impact by minimizing social life  and  if one 
infected with TB, other family members  will also  be  vulnerable were found to be 
significantly related to stigma (annex 11). 
 5.5 Stigma and TB 
The stigma associated with TB often discourages patients from seeking treatment. This study 
established that 64.8% of the highly stigmatized patients were found seeking care for TB 
after 60 days of onset of symptoms. The stigma attached to TB in many cultures may make 
people uneasy in revealing their illness, since they fear being isolated by their families and 
society. In many cases, stigma has therefore been found to be a major compelling reason for 
people with TB to keep their disease secret. Several studies in different socio-cultural 
contexts, such as, Vietnam, have come up with evidence that stigma is closely attached with 
TB, and results in delay in seeking health care (Meursing, 1997; Liefooghe, 1997).   
In this study, stigma was found to have statistical significance on patients’ delay in seeking 
TB treatment before and after controlling for confounding as well as in linear regression 
analysis. Similar findings were also found in other studies (WHO, 2006b). In this study, 
stigma scores attributed to 10.4% of variation in patient delay. The remaining about 90% was 
attributed by other factors not in the model. It was also noted that as percentage stigma scores 
increased, the patient delay also tended to increase.  
5.6 Type of the first contact health care provider 
This study found that 35% of the TB patients had visited traditional healers on discovering 
they had TB while others visited pharmacies, doctors’ private clinics, village health workers 
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and a small number TB clinic. Slightly over three-quarters (78.7%) of the patients who first 
consulted traditional healers on learning they had TB were found to have delayed in seeking 
treatment as opposed to those who went to other health care providers (p<0.05). In this study, 
patient delay was found to be significantly associated with the type of first contact health 
care provider, although this was not the case when confounding was controlled for. In Kenya, 
Liefooghe, et al, (1997) had also reported similar findings particularly the prolonged         
self-treatment and consultation with the traditional healers.  The practice of seeking treatment 
from such health care providers lead to delay in TB treatment and therefore increase 
transmission of the disease as well as worse prognosis for such patients. This problem could 
be tackled if awareness campaigns could be used as strategy to enlighten the public on the 
causes, transmission and preventive measures against TB, as well as importance of early 
seeking treatment in TB treatment. 
5.7 Accessibility to the treatment centre. 
Accessibility to diagnostic health facilities is an issue of equity in patients’ health and more 
so with TB control programmes. In this study, accessibility to health care was measured by 
reflecting on the physical distance (as opposed to looking at the perspectives of health rights, 
economics and socio-cultural) in kilometers from the patients’ residence to the treatment 
centre. Distance to the treatment centre was found to influence patients’ delay in seeking 
treatment as evidenced by analyses from both cross-tabulation and linear regression (p<0.05). 
Patient delay was found to increase with the distance to the treatment centre. Patients who 
traveled more than five kilometers had higher percentage delay than patients who traveled 
less than five kilometers. Liefooghe, et al. (1997) reported that the main reasons for delayed 
presentation of TB include lack of understanding about TB, the stigma associated with the 
disease, inaccessibility of treatment centres and a preference for private practitioners. The 
study findings also concur with those found by Madebo T, and Lindtjørn B. (1999). 
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7.0 CONCLUSION 
 
The following were the study conclusions: 
1. The study found that the majority (54%) had a significant delay in seeking care beyond a 
reasonable cutoff, as seen in similar societies to Somalia, to Zamzam TB clinic and 
continue to serve as reservoirs of infection. Patients took a median time of 68 days from 
onset of symptoms to treatment, with older people exhibiting more delay than their 
younger counterparts. 
2. The TB patients at Belet-Weyne generally had average levels of knowledge and 
perceptions about TB. Knowledge on signs and symptoms across the study population 
was at a good level. It was also noted that overall knowledge regarding transmission, 
prevention and recovery among respondents were quite low. Despite the respondents’ 
average knowledge on TB, these were misconceptions on causes of TB, such as, bad 
cold/fever, hard work and trauma, smoking, hereditary factors, witchcraft and shaking 
hands, among others.  More importantly, knowledge did not appear to affect delay in 
seeking treatment. 
3. Level of perception was found to have a statistically significant effect on treatment delay. 
4. Age and distance to the treatment centre were found to significantly influence treatment 
delay when other factors are not controlled for (from linear regression analysis 
conducted). 
5. In this study, stigma was found to be a major contributing factor to delay in seeking TB 
treatment in Belet-Weyne. About two-thirds (64.8%) of highly stigmatized patients were 
found to have delayed in seeking treatment for over 60 days as compared to 41% of those 
not stigmatized. 
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6. The results of this study indicate that patients in lower income brackets (<$30 per month) 
had a higher percentage of treatment delay than those patients with monthly income 
greater than $ 30. However, income had no statistically significant effect on treatment 
delay. 
7. Level of education was found to be associated with delay, although not the case when 
confounding was controlled for. 
8. The study found that the type of the first contact health care provider (i.e. village health 
workers, traditional healers, pharmacies, etc.) was associated with patient delay. This was 
confirmed from cross-tabulation analysis, but not by logistic regression analysis. 
  7.1 RECOMMENDATIONS FOR IMPLEMENTATION 
1. There is need for TB care and treatment providers to educate the community (including 
TB cases) on causes, transmission, prevention and recovery in order to improve their 
knowledge on tuberculosis.   
2. TB care and treatment providers should implement educational programmes focusing on 
reducing stigma and improving perceptions regarding TB in communities as well as in 
health institutions. Tackling the problems of misperceptions, as evidenced by the study, 
would be a strategy to deal with stigma and thus reduce delay. 
3. There is need for public health facilities to increase accessibility, especially targeting 
patients with high potential for delay in seeking treatment.  
4. Private health practitioners (e.g. Traditional healers, Pharmacists, etc.) should be trained 
in handling TB cases especially in early diagnoses.   
Recommendation for Further Study:   
Qualitative data collection techniques should be employed in subsequent studies to 
understand reasons behind the delay for pulmonary TB treatment. 
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Annexes 
Annex 1: Questionnaire 
 
All questions are to be addressed to the TB patients aged > 15 years, at TB centre. 
Date of interview___/___/____ (dd/mm/yyyyy) interviewer:_____________ ID#.____ 
SECTION A:  Socio-Demographic Information  
Q1.Age (in years (15 and above)___________. Q2.Gender: 1=Male   2=Female/  Q2 What 
is your current marital status? 1= Married  2= Single  3= Widowed  4= Separated  5= 
Divorced 
Q3. What is your highest level of education?1 = Illiterate 2= Literate/Primary (1-5) 3=. 
Lower secondary (6-8) 4= Secondary (9-10) 5= Higher Secondary or more (11+) 
Q4. What is your employment status? 1= Skilled worker 2= I Unskilled worker 3= 
Subsistence farmer 3=. Unemployed 4= Business 5= Other (specify__________ 
Q5. What is your residence status? 1=. Resident (local) 2=.IDPs 3= Internal migrant 4 = 
Returnees 5= others 
Q6. How much is your average monthly income?(in USD )  USD ___________ 
Section B. Onset of symptoms 
Q6.When was the onset of symptoms of this disease first started or you realized? (e.g. 
evening fever, night sweats, coughing, and loss of weigh] which of these?  
______/_____/_______ (dd/mm/yyyy) 
If the exact date is not available, then code: ________ (1, 2, 3, or 4) 
Note: 
 Code 1 = 04, if started in the first week of the month 
 2 = 11, if started in the second week of the month 
 3 = 18, if started in the third week of the month 
 
 
 
 
ii 
 
 4 = 25, if started in the fourth week of the month 
Even if it is not available in above coding, then code: ________ (05, 15, or 25) 
Note: code 05, if started in the early days of the month 
15, if started in the middle days of the month 
25, if started in the end days of the month 
Q7. Whom did you seek treatment when you first experienced major symptoms of TB? 
1= Drug shops / pharmacies 2= . Private  3= Village health worker 4= Traditional healer 5= 
TB clinic /DOTs Clinic 6= Others(specify____  
Q8. Treatment commencement-(Information to be obtained from TB Registers/Patient's 
Treatment Cards) 
      Treatment start date   ____/____/_______(dd/mm/yyyy 
Q9. How far is it from your original residence /home to the current DOTS centre where 
you are now started -TB drugs? (state the approximate distance in Km and travel time in 
minutes for one way). _______ Km. _______ Min. 
 
 
 
 
iii 
 
Section: III.  Knowledge of TB 
Put following the correct answer (1)  and incorrect answers (0)]according to patients 
response only . 
  Questions     YES   NO 
I What did you know about the cause of TB?-[causes of TB]   
1  TB can  caused by smoking and alcohol   
2 TB is communicable disease caused by germs/micro-organism   
3 TB can be caused by hard work or trauma    
4 Witch/evil-eye   
5 Cold   
6 TB is one of the hereditary disease     
II 
What did you know about the most important symptom of TB?( 
Signs  and symptoms)     
 8. Coughing more than three weeks      
 9.  Fever in the evening and night      
 10. Chest pain      
 11.  Cough with blood      
12   Headache    
 III. What did you know how is TB transmitted mainly?-[Transmission      
15 Near by coughing from a TB patient       
 16.. Having common utensils/food       
17. Hand shaking   
18. Others (specify) _________   
IV What did you know how is TB diagnosed mainly? Diagnosis )       
 19. Blood examination        
 20. Recognizing signs and symptoms      
 21 TB can diagnosis by sputum positive     
22.. Chest X-Ray    
23 General body examination   
24 Stool and urine examination   
23. Others (specify)    
V  
What did you know how is TB  is prevented mainly?, ( TB 
Prevention )    
24.  Through vaccination    
25. During coughing and sneezing the mouth and nose should be covered   
 
 
 
 
iv 
 
26. Avoid staying in crowded place to prevent getting TB transmission    
27.  
Avoid being air conditioning room with smoking people to prevent 
getting TB infection.   
 VI. What did you know about the recovery of TB?(treatment of TB     
28. Curable through medication     
 29.  Self-recovery     
 30. Praying with God     
 31. Traditional healing     
32 Cannot be cured   
 
 
 
 
 
v 
 
5.0. Section: D. Perception of TB (Attitudes and Beliefs about Tb)  
 Statement  Agree    Uncertain  Disagree 
I Perceived susceptibility      
1. 
If you get close contact with TB patients  you 
will easily  get TB infection     
 
2. 
If you eat food together with TB patient you can  
easily  get infected     
 
3. 
If you live in a crowded environment you can 
easily get TB infection     
 
4. 
If one member is infected with TB, other 
members will be vulnerable too .     
 
II Perceived  Severity      
5. 
Getting sick with TB, could  lead to loss of  
your ability of your working     
 
6. 
When you get infected you cannot work to earn 
your living as usual.     
 
7. Most TB patients hardly have social activities      
8. 
TB is a serious illness, you may have fatal  
outcome if untreated     
 
III Perceived benefits      
9. 
Anti TB drugs  can stop the transmission of the 
disease     
 
10 Anti-TB drugs  can decrease  TB death rate      
11 
Poor or rich TB patients have equal chance to 
be treated with anti –TB     
 
12. 
TB patients who completed their treatment  can 
live happily a normal life     
 
IV Perceived  barriers      
13. It is rather difficult  to take  anti TB-drugs      
14. 
When receiving TB drugs from the clinic, most 
of the health workers are friendly with you.     
 
15. 
You feel it a waste of time while undergoing 
treatment with anti-TB drug     
 
 
 
 
 
vi 
 
16. 
The expenses for TB treatment are costly ( e.g. 
Traveling ,no social    s support etc )     
 
Please mark the correct answer [√] according to your opinion on the following 
statements 
 
Stigma  
What did you think/feel about the following statement? 
 
 
 Statement  YES   
NOT 
SURE 
 NO 
1 
You were preferred to stay away from your neighbours and friends, 
when you got TB first time.     
 
2 People would become lonely when they got TB.      
3 
Being a TB patient, you are treated very normal in your family, as 
before.     
 
4 
Being a TB patient, you are reputed very normal from your 
neighbors, as before   
 
5. 
In our society, it is difficult to get married for an unmarried young 
person who got TB.     
 
6 TB is the disease of the poor people only.      
7 In fact, TB is caused as the punishment for sinful act.      
 
 
 
 
 Annex2: Questionnaire – Somali version 
 
Weydiimaha sahanka TB 
Waraysigani waxaa lala yeelanayaa oo keliya Bukaaanada cusub oo ay xaakadoodu (+) 
ka tahay , Dad’doodu  ka weyn tahay  15 sano ee ku sugan xarunta  TBda . 
Taariikhda waraysiga ___/___/____ (dd/mm/yyyyy     Warayste:____________ NO#.____ 
Qyebta A:   Warbixinta Xaalaadda Guud  
Q1. Da’da (Qor inta sano uu bukaanka jiro)__________. Q2.Jinsiga : 1=Lab   2=Dhedig  
Q3  Xaaladda  Guurka ?  1=  Xaas  2= Aan weli  guursan  3= Garoob   4=  kala tegay   5= 
La furay  
Q4.  Heerka waxbarshada ? 1 = Aan waxba qorin   2= Dugsi hoose (1-5)  3=. Dugsi  dhexe 
(6-8)  
4= Dugs sare  (9-10)  5= Jaamacad  iyo wax ka sareeya  (11+) 
Q5. Xaaladda shaqada? 1= Shaqaale  xirfad leh  2= Xoogmaal  3=  Beeraleey 3=. Aan 
shaqeyn   
4=  Ganacsi  5= kuwo kale (Caddee__________ 
Q6. Xaaladda Deegaanka ? 1=. Deegaan  2=. Soo Barkacay 3= Dal doorsi ku yimid   4 = 
Qaxooti soo noqday  5= Kuwo kale ( caddie-------------) 
 Q7. Celceliska dakhliliga  ee bisha  ku soo gala ?(Doolar ahaan))  USD ___________ 
 Qeybta B. xilliga Cabashada, xilliga daawada,Goobaha daawada iyo foogaanta. 
Q8 Ma xasuusan kartaa xilligii kuugu horeysay  oo aad dareentay caalamadaha ugu 
culus  ee Xanuunkan( sida qandhada fiidkii, dhidka habeenka qufac iyo miisan dhac)  
______/_____/_______ (dd/mm/yyyy)  
Q9. Goorta Daawada loo bilaabay -(Ka  fiiri Kaarka daawada amd diiwaanka ) 
      Taariikhda daawada loo 
billabay  
____/____/_______(dd/mm/yyyy 
Q10.  Xagee ayaad macin  biday markii kuugu  horeysay oo aad isku  aragtay 
/dareentay calaamdadha cudurkan? 1= Farmasi  2= . Goob caafimaad gaar ah  3= 
Daryeele caafimaad  4= Daawo dhaqameed 5= Xarunta TB  6= Meelo kale (Caddee____  
Q11.Masaafo intee  la’eg ayey kuu jirataa xaruntan aad hadda daawada ka qaadato iyo 
Degaankii rasmiga ahaa ood ka  timid ? (sheeg Kilomitarka ugu dhaw iyo waqtiga safarka 
ee soo socod keliya ). _______ Km. _______ Min. 
Qeybta : C  Aqoonta bukaannada ee Cudurka TB 
 
 
 
 
 Dooro Jawaabta ugu saxsan oo geli  (1) ,Jawaabaha khaldanna  u isticmaal ( 0) adigoo 
isticmaaalyaya fahamkaaga . 
  Weydiimo     YES   NO 
I 
Maxaad ka taqaannaa wayaabaha Sababa cudurkan 
qaaxaada?   
1  Cudurkan  waxaa sababa sigaar cabista iyo Qamariga .   
2 
Cudurkan waa cudur faafa oo ay sababaan jeermi ama Noole 
dahsoon    
3 Cudurkan waxaa sababa shaqda adag iyo Jug    
4 Sixir ama Isha biniaadmiga    
5 Hargab xumaaday    
6 Cudurkan  waxa uu ka mid yahay cudurada la iska dhexlo    
II 
Maxaad ka ogtahay caalmadaha iyo cabashooyinka  ugu 
caansan cudurkan ?     
7. Qufac ka badan muddo  Seddex Todobaad ah       
 8.  Qandho Galabtii  iyo Habeenkii ah       
 9. Xabad  xanuun       
 10.  Qufac uu dhiig la socdo      
11   Madax xanuun     
 III. Maxaad ka ogtahay sida uu inta badani ku fido cudurkan ?     
12 Bukaha  oo ku qufaca qof agtiia  jooga        
 13. Cuntada oo la isla cuno ama weelasha oo la isla isticmaalo/       
14 Salaan   
IV 
Maxaad  ka ogtahay sida inta badani cudurkan lagu ogaado 
ama lagu xajiiyo )       
15. Dhiigga oo la baaro         
 16. Waxaa lagu gartaa calaamadha iyo cabashada bukaha .     
 17 Waxaa la ogaadaa Candhuufta oo noqota (+)     
18. Raajada Feeraha    
19  Baaris guud ee jirka    
20 Saxarada iyo kaadida oo la baaro.   
V  
 Maxaad ka og tahay siyaabaha inta badan looga hortagi 
karo cudurkan ?    
 
 
 
 
 21. Iyadoo la deegsado Talaal    
22. Afka iyo sanka oo la daboolo xilliga Qufaca ama Hindhisada .   
23. In aad iska illaaliso tegidda meelaha dadku ku badan yahay   
24.  
In aad iska ilaaliso Joogista guryaha marwaxadaha leh  oo ay 
joogaan dad sigaar caba    
 VI. 
Maxaad ka taqaan siyaabaha looga bogsoon karo 
cudurkaan?     
25. Waxaa looga raysan karaa iyadoo daawo la qaato.     
 26.  Waxaa looga raysan karaa Iskiis      
 27. Alle oo la baryo.     
 28. Daawo dhaqameed       
29 Lama daaweyn karo   
 
 
 
 
 
 5.0. Qeybta: D. Aragrtida bukaanada ee cudurka -Fadlan ku qor Sax [√] haddallada 
hoos ku qoran, adigoo adeegsanaya ra,ayigaada  
      Mowduuc   
Ku 
Raacay 
Ma 
hubo 
Kuma 
Raacsani 
 I Aaminsanaata  u  Noglaashaha cudurka      
 1. 
Haddii la joogtid Bukaan TB qaba , waxaa si sahlan kuugu 
dhici karo cudurka    
 
 2. 
Haddii aad la cuntayso bukaan qaba TB, waxaa si sahlan kuugu 
dhici karo cudurka    
 
 3. 
Haddii aad ku nooshay meel isku raran ah , waxaa si sahlan ah 
ku qaadi kartaa cudurka    
 
 4.   
Haddii xubin qoyska ka mid ah ay qabto cudurkan,Xubnaha 
kale ee qoyskana way u nugulaadan   
 
 II Aaminsanaata  Khatarta cudurka      
    
5. 
Qaaxadu waa cudur halis ah oo geeri sababi kara haddii aan la 
daaweyn   
 
    
6. Inta badan bukaanada TB ma qaban karaan shaqooyin culus   
 
 7. Qaaxadu  waa cudur aan sinaba looga bogsoon karin       
8 
Qaaxadu ma aha cudur halis ah – Howlahaada ayaad wadan 
kartaa.   
 
 9 Hadii cudurkan  ku haleelo, waxaa ku dhici karo shaqo la’aan .    
 III        Aaminsanaata  waxtarka daaweynta     
 10. 
Daawooyinka cudurkani  waxay joojin karaan fiditaanka 
cudurka     
 
 11. Daawada cudurkani  waxay yareyn kartaa heerka dhimashada     
 12. 
Bukaanada TB ( faqiir iyo qaniba) way u siman yihiin  
daaweynta cudurka TB     
 
  13 
Bukaanka daawada dhamaystaa waxuu ku noolan karaa nolol 
wacan oo raaxo leh   
 
 IV. Aaminsanaata Caqabadaha cudurka       
  14 Qaadashada daawada TBda ma aha  wax fudud .     
 15 
Shaqaalaha caafimaadku waa ku  jeclaanayaan marka aad 
daawada qaadanayso    
 
 16.   
Waxaad dareemaysaa waqti lumis xilliga ay daaweynta TBdu  
kuu socoto   
 
 17 
  
Kharashyada daaweynta cudurkan waa mid aad culus( 
nolosha,safarka iwm)   
 
 
 
 
 
 Takoorid /Dhaleecayn 
 
 
Akhbaar -  Maxay kula tahay  Hadallada hoos ku 
qoran ? Haa Ma hubo 
Maya 
1. 
Waxaad doorbi lahayd in aad ka haaajirto 
deriskaag/asxaabta markii cudurku ku asiibay   
 
2. 
Dadku waxay dareemaan Cidlo markii ay Qaaxo ku 
dhacdo.   
 
3. 
Ka bukaan ahaan , qoyskeygu  si caadi  aha ayuu illa  
dhaqmaa.   
 
4 
Ka bukaan ahaan, deriskeygu si caadi aha ayuu iila  
dhaqmaa .   
 
5 
Bulshadeena  way ku  adag tahay in la guursado  qof 
ay TB ku dhacday .   
 
6 
Cudurka  Qaaxadu waa cudur haleela dadka Faqriga 
oo keliya    
 
7. 
Dhab ahaantii,Qaaxadu waa sabab u tahay ciqaab 
danbiyeed dadku geystay   
 
 
 
 
 
 
  
Annex 3: Consent form 
 
PARTICIPANT INFORMATION SHEET 
Researcher: Abukar Yusuf Nur  
MPH student, School of Public Health, University of the Western Cape, South Africa  
Supervisor: Jon Rohde, MD  
Professor of Public Health, UWC, School of public health  
------------------------------------------------------------------------------------------------------------ 
Title of the study:  Factors influencing Delays in seeking TB Treatment in Belet-weyne 
District, in Somalia. 
Study site:  Zamsam TB Treatment centre Belet-weyne, Central Somalia. 
Study background /Purposes  
You are invited to participate in a research study on delay for pulmonary TB treatment. As 
you are aware, many TB patients in our community are seeking care quite late. This causes 
problems to the individuals and to the society as a whole. It is therefore important to have an 
understanding of extent of delay for getting appropriate diagnosis and treatment of the 
disease.  
We also need a better understanding of what factors could be influencing such delays. The 
information you provide on the basis of your experiences as a TB patient will help to develop 
policies and interventions aimed at reducing delay. 
You are selected as a possible participant because you are a client of this treatment centre. A 
total of 137 people will be enrolled in this study. We ask that you read this form and ask 
questions you may have before agreeing to be in the study. 
 
 
 
 
 What will I have to do? (Procedures) 
If you agree to participate in this study, we would like to ask you to take part in a survey that 
will take you about 30 – 40 minutes to complete. You will be asked about your TB treatment 
seeking history and your understanding about the disease, perceptions and some details about 
your age, education and employment. 
Why have I been asked to take part in the research work? 
You have been requested to take part in this research work because we can learn from your 
experience of seeking TB treatment. 
What are the risks and discomforts? 
If you take part in this study, 
There are no foreseeable physical and mental risks to you. However, you might feel 
uncomfortable recalling information about yourself and your actual practices regarding TB.  
Confidentiality will be upheld for information shared about your family income and your 
choice of health care providers. You may skip any question you do not want to answer or 
may discontinue taking part in the survey at any time. 
What is being done to maintain confidentiality? 
All your answers will be confidential. The steps I will take to protect your confidentiality are: 
I won't tell anyone, whether you take part in this study or not. 
Your answers on the study will be kept confidential to the extent allowed by law, and  there is 
no way we can link your name with your answer on the questionnaire, so, the whole process 
of study will be done in a way that no one could ever guess your participation in this study. 
All the information documented will be kept locked so that none other than I, Abukar Yusuf 
Nur (researcher), and my research supervisor, Dr. Jon Rhode, will be able to see it. 
What will be the benefits by taking part in this study? 
 
 
 
 
 There will be no direct benefit to you, but your participation is likely to help in understanding 
the delays in TB treatment and may help in developing policies and programmes for reducing 
delays in TB treatment in the future. 
Any Incentives? 
You will not be provided any incentive to take part in this research work. 
What happens if I do not take part in this study? 
You do not have to take part in this study. Your participation is voluntary. 
You can change your mind and stop at any time. 
Your refusal to participate in this study will not affect your right to your current or future 
treatment. 
Any Questions? 
You are encouraged to ask any questions now or later. 
If you wish you may contact and talk to the researcher at: 
Abukar Yusuf Nur  
C/O Food security Analysis Unit –Somalia  
Tel: 2525-63-52000(Res.),Cell ph:+2521-564186 
E-mail: Abukaryn@ yahoo.com 
Or the research supervisor: 
Professor Jon Rohde, School of Public Health, University of the Western Cape  
E-mail:jrohde@msh.org 
 
 
 
 
 Annex 4: Consent form 
 
INFORMED CONSENT FORM 
Project Title: FACTORS INFLUENCING DELAYS IN SEEKING TB TREATMENT IN 
BELET-WEYNE DISTRICT, IN SOMALIA. 
Responsible person(s) and  Institute:  
Abukar Yusuf Nur, MPH student, School of Public Health, University of the Western Cape, 
South Africa 
Supervisor: Dr. Jon Rohde MD, Professor of Public Health, UWC, School of public health  
Date of consent………………………………… ( day/ month/year) 
(Mr. / Mrs. / Ms.) First name……………………..Last name…………………… 
Home address……………………….……………… 
I have read the information sheet or it has been read to me and I understand the details about 
the objectives and methodology of the study and the possible risks and benefits that may 
occur to myself or to my child by participating in the study. I voluntarily participate in the 
study and I understand that I may choose not to answer any question or to withdraw from the 
study at any time. I understand that the information will be kept confidentially. My name or 
child’s name will not be presented in the study report. I understand that I shall be given a 
copy of the signed consent form to keep. 
 
Signature……………………………...(Respondent/informant) 
(Mr./Mrs./Ms………………………………………………….) 
Signature………………………………………….(Researcher) 
 
 
 
 
 (For persons who cannot read and write). 
I cannot read but before signing my consent, the investigator/interviewer read the information 
sheet and the informed consent form to me. 
Signature / thumb stamp…………………… (Respondent/informant) 
 
Signature………………………………………….(Researcher) 
(………………………………………....) 
Signature…………………………………………...(Witness) 
(…………………………………………) 
 
You are encouraged to ask any questions now or later. If you wish, you may contact and talk 
to the researcher at: 
Abukar Yusuf Nur  
C/O Food security Analysis Unit –Somalia, Tel: +2525-63-52000(Res.), Cell:+2521-
564186 
E-mail: Abukaryn@ yahoo.com  
Or the research supervisor: 
Professor Jon Rohde  
School of Public Health, University of the Western Cape 
E-mail:jrohde@msh.org 
 
 
 
 
 
 Annex 5: Work plan 
 Mar'06  Apr Apr06  Ma‘06 May’06 
Jun'0
6 June ‘06 06  2007 J-jul Aug07 
Sept’07 Oct’07 
  Time/Activity 19-31 1-6 7.-12 5-11 19-25 26-31 1-8 9-19 Oct/ 
Nov 
Feb14 May 
 
June 
2-8 
9-31 1-31   
1 Framing the Research 
question  
    
 
                    
  Meeting with 
Stakeholders 
  
 
                      
2 Formulating aims and 
objectives  
  
 
  
 
                  
3 Literature Review                            
4 Share draft with 
lecturer(e.g. sending draft 
for comments  
                          
5 Submission of first 
assignment  
                          
6 Methodology/study 
designs, sampling  
                          
7 Development of data 
collection instruments  
                          
8 Plan for analysis (dummy 
tables) 
                          
9 Proposal Development                           
 
 
 
 
 10 Submit draft research 
protocol 
                          
11 Refine  research proposal                           
12 Submission for clearance                 
13 Translate questionnaire                           
14 Identify enumerators                           
15  Meeting with Clinic staff 
, and other stakeholders 
                         
16 Training of enumerators                           
17 Pretest questionnaire                            
18 Logistics  preparation                            
19  Data collection,& entry                           
20 Analyze data                            
21  Share preliminary results 
with partners/stakeholders 
                          
22 Report writing                           
23 Share actions- 
stakeholders 
                          
24 Follow up  
implementation  
                          
 
 
 
 
 Annex 6: Budget 
     
ITEM Unit  cost 
(USD) 
Multiplying 
Factors 
TOTAL Cost 
/USD 
1. Allowances/per diems 
a. Researcher(1) 
-Training of enumerators and pr-testing $ 25/day 1x2= 2 days 50 
-data collection $45/day 1x5= 7days 315 
b. Enumurators /Research assistants (3) 
-during training /pre-testing $10/day 3x2= 6days 60 
-during data collection $15/day 3x 5= 15days 225 
c. Data assistants 
-Translating questionnaire into Somali(1) $35 1x3= 3days 105 
-Data entry clerks $15 2x4=8days 120 
Subtotal 995 
2) Stationary 
-Plain Paper, A4 size 7.2 2 rim 14.5 
- Pen, Black Ink 5.7 1 dozen 5.7 
- Printer Cartridge 35.00 2 pcs 70.0 
- photocopy , Journal, article 0.14 100 pages 14.5 
- photocopy of questionnaires 0.14 1850 copies 259.0 
photocopy, Thesis/proposal 7.2 3copies 21.6 
Subtotal 385.3 
D) Other costs 
-Refreshments(during meetings+ training) - - 42.0 
Subtotal 42.0 
Grand Total 1,423 
 
    
 
 
 
 
 
  
Annex 7: Results of Logistic regression analysis( cutoff =60 days) 
Variable B S.E. 
Wald’s statistic 
(χ2) df p-value Odds ratio 
95.0% C.I for odds 
ratio 
            Lower Upper 
 Age (groups) .475 .251 3.592 1 .058 1.608 .984 2.628 
  Monthly income .110 .364 .092 1 .762 1.117 .547 2.279 
  Level of education -.156 .233 .446 1 .504 .856 .542 1.352 
  Level of stigma .965 .443 4.736 1 .030 2.624 1.101 6.254 
  Type of first contact -.041 .130 .101 1 .751 .959 .743 1.239 
  Distance (KM) .333 .231 2.085 1 .149 1.396 .888 2.195 
   Overall knowledge   of TB .460 .554 .691 1 .406 1.585 .535 4.689 
  Overall perception of TB -1.000 .504 3.937 1 .047 .368 .137 .988 
  Constant -1.665 1.705 .953 1 .329 .189   
 
Annex 8: Results of Logistic regression analysis.(cutoff =120 days) 
  B S.E. Χ2 Df Sig. Odds ratio 
 Tye of first contact .090 .131 .477 1 .490 1.094 
   Monthly income -.006 .009 .472 1 .492 .994 
  Distance to TR centre .011 .013 .699 1 .403 1.011 
   Level of educaion -.004 .253 .000 1 .986 .996 
  Level of stigmatization 1.001 .483 4.302 1 .038 2.721 
  Over all  perception -.127 .496 .066 1 .797 .880 
  Overall Knowledge  on TB .096 .094 1.047 1 .306 1.101 
  Age .386 .252 2.342 1 .126 1.471 
  Constant -4.117 2.183 3.556 1 .059 .016 
Annex 9: Results of Logistic regression analysis.(cutoff =75 days) 
 B S.E. Χ2 df Sig. Odds ratio 
 Type of first contact .042 .127 .109 1 .742 1.043 
  Monthly income  .001 .008 .014 1 .904 1.001 
  Distance to TR centre -.001 .013 .008 1 .930 .999 
   Level of education -.312 .246 1.612 1 .204 .732 
  Stigmatization 1.184 .469 6.384 1 .012 3.268 
  Overall perception -.398 .478 .694 1 .405 .672 
  Oveall Knowledge on 
TB 
.195 .092 4.492 1 .034 1.216 
  Age .336 .245 1.885 1 .170 1.399 
  Constant -4.203 2.080 4.083 1 .043 .015 
 
 
 
 
  
Annex 10: Results of Logistic regression analysis.(cutoff =45 days) 
 B S.E. Χ2 df Sig. Odd ratio 95.0% C.I. 
  Lower Upper Lower Upper Lower Upper Lower Upper 
Step 
1(a) 
Stigma .923 .487 3.597 1 .058 2.517 .970 6.531
  Overall 
perception .457 .481 .905 1 .342 1.580 .616 4.055
  Level of 
education -.035 .244 .020 1 .886 .966 .599 1.558
  Age .688 .260 7.001 1 .008 1.991 1.195 3.315
  Monthly 
income  -.004 .008 .201 1 .654 .996 .980 1.013
  Overall 
knowledge .169 .095 3.139 1 .076 1.184 .982 1.428
  Constant -4.706 2.046 5.287 1 .021 .009   
Annex 11: Summary of relationships between various items on perception and 
Stigma. 
 B S.E.  df Sig. 
Odds 
ratio 95.0% C.I. 
    Χ2    Lower Upper 
Close contact with TB patients  .180 .453 .158 1 .691 1.197 .493 2.909
Living in crowded environment  -.327 .451 .524 1 .469 .721 .298 1.746
If one member is infected with TB, other 
members will be vulnerable too. 1.034 .479 4.647 1 .031 2.811 1.098 7.194
Getting sick with TB, could  lead to loss 
of  your ability of your working  .264 .373 .503 1 .478 1.303 .627 2.705
TB is a serious illness  -.054 .426 .016 1 .900 .948 .411 2.186
Lack/Minimised social life  1.125 .491 5.240 1 .022 3.079 1.176 8.066
TB can’t be cured  -.305 .324 .887 1 .346 .737 .390 1.391
Tb is not serious ,you can go on working 
anyhow  .741 .313 5.622 1 .018 2.099 1.137 3.874
Anti-TB drug can stop the transmission -.103 .487 .045 1 .832 .902 .347 2.342
Anti-TB drug can decrease death rate .693 .457 2.298 1 .130 1.999 .816 4.895
Poor or rich TB patients have equal 
chance to treatment  .530 .364 2.121 1 .145 1.699 .833 3.465
TB patients who completed their 
treatment can live happily -.795 .458 3.012 1 .083 .452 .184 1.108
It is difficult to take anti-TB drugs  .726 .386 3.540 1 .060 2.067 .970 4.405
Access to TB drugs from hospital difficult .229 .377 .369 1 .544 1.258 .600 2.634
Time is wasted undergoing treatment with 
anti-TB drug 
 
-.226 .406 .311 1 .577 .797 .360 1.766
It is expensive to get TB treatment .613 .365 2.822 1 .093 1.846 .903 3.775
Constant -8.011 1.596 25.199 1 .000 .000   
 
   
 
 
 
 
